Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 10, 2026

Primary Completion Date

June 15, 2027

Study Completion Date

July 15, 2027

Conditions

Coronary Artery Disease

Interventions

DEVICE

RespirAct

RespirAct device-based computer-controlled gas delivery at different concentrations as per protocol

Trial Locations (1)

IU Health Methodist Hospital, Indianapolis

All Listed Sponsors

lead

Indiana University

OTHER

NCT06253884 - Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease | Biotech Hunter | Biotech Hunter